AAAAAA

   
Results: 1-12 |
Results: 12
LONG-TERM COMBINATION HBIG AND LAMIVUDINE IS HIGHLY EFFECTIVE IN PREVENTING RECURRENT HEPATITIS-B IN ORTHOTOPIC LIVER-TRANSPLANT (OLT) RECIPIENTS
Authors: HAN SH MARTIN P MARKOWITZ J HOLT C ARTINIAN L KUNDER G GOLDSTEIN LI GOSS J SEU P BUSUTTIL RW
Citation: Sh. Han et al., LONG-TERM COMBINATION HBIG AND LAMIVUDINE IS HIGHLY EFFECTIVE IN PREVENTING RECURRENT HEPATITIS-B IN ORTHOTOPIC LIVER-TRANSPLANT (OLT) RECIPIENTS, Hepatology, 28(4), 1998, pp. 238-238
A DISEASE-TARGETED MEASURE OF HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) FOR PATIENTS WITH CHRONIC LIVER-DISEASE - THE LDQOL 1.0(C)
Authors: GRALNEK IM HAVS RD ROSEN HR KEEFFE EB ARTINIAN L KIM S MARTIN P
Citation: Im. Gralnek et al., A DISEASE-TARGETED MEASURE OF HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) FOR PATIENTS WITH CHRONIC LIVER-DISEASE - THE LDQOL 1.0(C), Hepatology, 28(4), 1998, pp. 274-274
A PROSPECTIVE CONTROLLED TRIAL OF TACROLIMUS VS. CYCLOSPORINE IN ORTHOTOPIC LIVER-TRANSPLANT (OLT) RECIPIENTS WITH HEPATITIS-C VIRUS - LACKOF EFFECT ON RECURRENT HEPATITIS
Authors: MARTIN P GOLDSTEIN RM GOSS J SEU P GOLDSTEIN JI STRIBLING R ARTINIAN L WU LL KLINTMALM GD BUSUTTIL RW
Citation: P. Martin et al., A PROSPECTIVE CONTROLLED TRIAL OF TACROLIMUS VS. CYCLOSPORINE IN ORTHOTOPIC LIVER-TRANSPLANT (OLT) RECIPIENTS WITH HEPATITIS-C VIRUS - LACKOF EFFECT ON RECURRENT HEPATITIS, Hepatology, 28(4), 1998, pp. 603-603
PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE FOLLOWING LIVER-TRANSPLANTATION USING COMBINATION LAMIVUDINE AND HEPATITIS-B IMMUNE GLOBULIN
Authors: MARKOWITZ JS MARTIN P CONRAD AJ MARKMANN JF SEU P YERSIZ H GOSS JA SCHMIDT P PAKRASI A ARTINIAN L MURRAY NGB IMAGAWA DK HOLT C GOLDSTEIN LI STRIBLING R BUSUTTIL RW
Citation: Js. Markowitz et al., PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE FOLLOWING LIVER-TRANSPLANTATION USING COMBINATION LAMIVUDINE AND HEPATITIS-B IMMUNE GLOBULIN, Hepatology, 28(2), 1998, pp. 585-589
PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE FOLLOWING LIVER-TRANSPLANTATION USING COMBINATION LAMIVUDINE AND HEPATITIS-B IMMUNE GLOBULIN
Authors: MARKOWITZ JS MARTIN P CONRAD AJ MARKMANN JF SEU P YERSIZ H GOSS JA PAKRASI A ARTINIAN L HOLT C GOLDSTEIN LI STRIBLING R BUSUTTIL RW
Citation: Js. Markowitz et al., PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE FOLLOWING LIVER-TRANSPLANTATION USING COMBINATION LAMIVUDINE AND HEPATITIS-B IMMUNE GLOBULIN, Hepatology, 26(4), 1997, pp. 95-95
HISTOLOGICAL AND VIROLOGICAL FEATURES OF HEPATITIS-C IN END-STAGE RENAL-DISEASE PATIENTS PRESENTING FOR RENAL-TRANSPLANTATION
Authors: FABRIZI F DANOVITCH G WILKINSON A DIXIT V BREZINA M STRIBLING R ARTINIAN L RUSSELL J CONRAD A GITNICK G MARTIN P
Citation: F. Fabrizi et al., HISTOLOGICAL AND VIROLOGICAL FEATURES OF HEPATITIS-C IN END-STAGE RENAL-DISEASE PATIENTS PRESENTING FOR RENAL-TRANSPLANTATION, Gastroenterology, 112(4), 1997, pp. 1262-1262
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CALCIUM SUPPLEMENTATION FORDECREASED BONE-DENSITY IN CORTICOSTEROID-USING PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A PILOT-STUDY
Authors: BERNSTEIN CN SEEGER LL ANTON PA ARTINIAN L GEFFREY S GOODMAN W BELIN TR SHANAHAN F
Citation: Cn. Bernstein et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CALCIUM SUPPLEMENTATION FORDECREASED BONE-DENSITY IN CORTICOSTEROID-USING PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A PILOT-STUDY, Alimentary pharmacology & therapeutics, 10(5), 1996, pp. 777-786
DECREASED BONE-DENSITY IN INFLAMMATORY BOWEL-DISEASE IS RELATED TO CORTICOSTEROID USE AND NOT DISEASE DIAGNOSIS
Authors: BERNSTEIN CN SEEGER LL SAYRE JW ANTON PA ARTINIAN L SHANAHAN F
Citation: Cn. Bernstein et al., DECREASED BONE-DENSITY IN INFLAMMATORY BOWEL-DISEASE IS RELATED TO CORTICOSTEROID USE AND NOT DISEASE DIAGNOSIS, Journal of bone and mineral research, 10(2), 1995, pp. 250-256
ORAL CALCIUM AND VITAMIN-D DOES NOT IMPACT ON DECREASED BONE-DENSITY IN INFLAMMATORY BOWEL-DISEASE (IBD) - A PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED STUDY
Authors: BERNSTEIN CN SEEGER LL ANTON PA ARTINIAN L GOODMAN WG GEFFREY SP BELIN T SHANAHAN F
Citation: Cn. Bernstein et al., ORAL CALCIUM AND VITAMIN-D DOES NOT IMPACT ON DECREASED BONE-DENSITY IN INFLAMMATORY BOWEL-DISEASE (IBD) - A PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED STUDY, Gastroenterology, 108(4), 1995, pp. 782-782
LOW-DOSE 6-MERCAPTOPURINE IN INFLAMMATORY DOWEL DISEASE IS ASSOCIATEDWITH MINIMAL HEMATOLOGIC TOXICITY
Authors: BERNSTEIN CN ARTINIAN L ANTON PA SHANAHAN F
Citation: Cn. Bernstein et al., LOW-DOSE 6-MERCAPTOPURINE IN INFLAMMATORY DOWEL DISEASE IS ASSOCIATEDWITH MINIMAL HEMATOLOGIC TOXICITY, Digestive diseases and sciences, 39(8), 1994, pp. 1638-1641
MILK TOLERANCE IN ADULTS WITH ULCERATIVE-COLITIS
Authors: BERNSTEIN CN AMENT M ARTINIAN L RIDGEWAY J SHANAHAN F
Citation: Cn. Bernstein et al., MILK TOLERANCE IN ADULTS WITH ULCERATIVE-COLITIS, The American journal of gastroenterology, 89(6), 1994, pp. 872-877
OSTEOPENIA IN INFLAMMATORY BOWEL-DISEASE (IBD) IS RELATED TO PREDNISONE USE AND NOT DISEASE DIAGNOSIS - A PROSPECTIVE-STUDY
Authors: BERNSTEIN CN SEEGER LL SAYRE JW ANTON PA ARTINIAN L SHANAHAN F
Citation: Cn. Bernstein et al., OSTEOPENIA IN INFLAMMATORY BOWEL-DISEASE (IBD) IS RELATED TO PREDNISONE USE AND NOT DISEASE DIAGNOSIS - A PROSPECTIVE-STUDY, Gastroenterology, 104(4), 1993, pp. 668-668
Risultati: 1-12 |